Niacin Extended Release

Niaspan; Slo-Niacin

Pictures

top jpg

---

art pc464029 fig2 gif

---

art pc464029 fig1 gif

Figure 1 Effects on low density lipoprotein LDL particles A change from baseline in LDL peak particle diameter p <0 001 vs atorvastatin p<0 001 vs simvastatin B percent change

---

art pc464029 fig3 gif

---

up 1142 jpg

is more effective at slowing the progression of heart disease than one medication alone according to a report in the medical journal Circulation Researchers reporting at the American Heart Association meeting in New Orleans say that adding extended release niacin a

---

niaspan 01 jpg

doses is an antihyperlipidemic agent Niacin nicotinic acid or 3 pyridinecarboxylic acid is a white crystalline powder very soluble in water with the following structural formula Niaspan ® is an unscored medium orange film coated tablet for oral administration and is available in three tablet strengths containing 500 750 and 1000 mg niacin Niaspan ® tablets

---

right cart 2 jpg

---

warnings jpg

---

3299 jpg

---

talk033 s035 cme gif

The ADvicor Versus Other Cholesterol modulating Agents Trial Evaluation ADVOCATE was designed to compare the efficacy of a niacin extended release ER

---

talk028 s030 cme gif

The ADvicor Versus Other Cholesterol modulating Agents Trial Evaluation ADVOCATE was designed to compare the efficacy of a niacin extended release ER

---

art pc494342 fig3 gif

Figure 3 Effects of niacin on high density lipoprotein HDL subclasses ER=extended release IR=immediate release or crystalline p <0 05 vs niacin ER and niacin IR 1500 mg d Adapted

---

art pc494342 fig2 gif

Figure 2 Effects of niacin on high density lipoprotein subclasses ER=extended release Reprinted with permission from Am J Cardiol 2003 91 1432 1436 8

---

niaspan gif

Niaspan Information NIASPAN extended release niacin is approved to prevent recurrent heart attacks in patients with high cholesterol but has not been shown to prevent the

---

i1 t jpg

In the first combination of its kind Abbott Laboratories has received FDA approval for its fixed dose product Simcor The new therapy contains both NiaSpan the company s extended release

---

1148 jpg

点击放大

---

1152 jpg

点击放大

---

1151 jpg

点击放大

---